STE · 10-Q · 2026Q3 · Full report

Revenue Performance and Mix

STERIS plc · 2026-11-05 · Importance 49 · Surprise 32 · From source text

For the six months ended September 30, 2026, revenue increased 8.1% to $3,081.3 million from $2,851.4 million, driven by higher volume in Healthcare and Life Sciences and higher pricing across all three segments. Service revenue rose 7.9% to $1,527.3 million, consumables rose 9.4% to $970.3 million, and capital equipment rose 6.3% to $583.7 million. U.S. revenue increased 7.8% to $2,264.9 million, other foreign revenue increased 8.7% to $761.4 million, and Ireland revenue increased 10.4% to $55.0 million.

Key facts

• STERIS revenues increased 8.8% to $1,588.6 million for the three months ended September 30, 2026, and increased 8.1% to $3,081.3 million for the six months ended September 30, 2026; increases reflected higher volume and pricing. source
• STERIS service revenues increased 8.0% in the three months and 7.9% in the six months ended September 30, 2026, reflecting growth in all three segments in both periods. source
• STERIS consumable revenues increased 9.8% in the three months ended September 30, 2026, reflecting growth in Healthcare and Life Sciences. source
• STERIS capital equipment revenues increased 9.2% in the three months ended September 30, 2026, reflecting growth in Life Sciences and Healthcare. source

Impact estimates